Cargando…
Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids()
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI).
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306746/ http://dx.doi.org/10.1016/j.rceng.2020.04.006 |
| _version_ | 1783548717323780096 |
|---|---|
| author | Varona Pérez, J. Rodriguez Chinesta, J.M. |
| author_facet | Varona Pérez, J. Rodriguez Chinesta, J.M. |
| author_sort | Varona Pérez, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7306746 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73067462020-06-22 Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids() Varona Pérez, J. Rodriguez Chinesta, J.M. Rev Clin Esp (Barc) Correspondence Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2020-11 2020-06-22 /pmc/articles/PMC7306746/ http://dx.doi.org/10.1016/j.rceng.2020.04.006 Text en © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Varona Pérez, J. Rodriguez Chinesta, J.M. Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids() |
| title | Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids() |
| title_full | Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids() |
| title_fullStr | Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids() |
| title_full_unstemmed | Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids() |
| title_short | Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids() |
| title_sort | risk of hepatitis b reactivation associated with treatment against sars-cov-2 (covid-19) with corticosteroids() |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306746/ http://dx.doi.org/10.1016/j.rceng.2020.04.006 |
| work_keys_str_mv | AT varonaperezj riskofhepatitisbreactivationassociatedwithtreatmentagainstsarscov2covid19withcorticosteroids AT rodriguezchinestajm riskofhepatitisbreactivationassociatedwithtreatmentagainstsarscov2covid19withcorticosteroids |